KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,490,400 | -20.7% | 580,000 | 0.0% | 0.33% | -15.7% |
| Q2 2023 | $23,304,400 | +81.9% | 580,000 | +93.3% | 0.39% | +67.7% |
| Q1 2023 | $12,810,000 | -29.4% | 300,000 | -29.8% | 0.24% | -3.7% |
| Q2 2021 | $18,152,000 | -31.0% | 427,414 | 0.0% | 0.24% | -37.4% |
| Q1 2021 | $26,307,000 | +7.8% | 427,414 | +23.5% | 0.39% | +4.3% |
| Q4 2020 | $24,407,000 | – | 346,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |